Who owns BeOne Medicines AG, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Baker Bros. Advisors LP: 8.0% · 115,457,154 shares — Baker Bros. Advisors (GP) LLC: 8.0% · 115,457,154 shares — Julian C. Baker: 8.0% · 115,912,814 shares
Capital International Investors: 4.2% · 65,211,266 shares
1 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of BeOne Medicines AG.
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of BeOne Medicines AG they hold. Together these 361 managers report 2.45% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $2.51B | 8,801,567 | 12.57% | 0.60% | June 30, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | $1.43B | 5,007,931 | 0.84% | 0.34% | June 30, 2026 |
359 more institutional holders behind a free account
See every manager reporting BeOne Medicines AG, how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 149 funds hold 0.72% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| New Perspective Fund | $759M | 0.45% | 0.18% | June 30, 2026 |
| EUPAC Fund | $200M | 0.14% | 0.05% | June 30, 2026 |
147 more funds behind a free account
See every fund holding BeOne Medicines AG and what share of its net assets the position represents.
Sign up freeLoading...
